Effect of influenza A virus infection on natural and adaptive cellular immunity

Clinical Immunology and Immunopathology

Volumn 79, Issue 3, 1996, Pages 294-302

  Skoner, David P ^a,c,e   Whiteside, Theresa L ^a,d   Wilson, John W ^b,d   Doyle, William J ^a,c   Herberman, Ronald B ^a,d   Fireman, Philip ^a,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLUENZA VIRUS A; INFORMED CONSENT; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029975448     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0082     Document Type: Article

References (57)

1. Lui, K. J., and Kendal, A. P. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am. J. Public Health 77, 712-716, 1987.
2. Glezen, W. P., Payne, A. A., and Snyder, D. N. Mortality and influenza. J. Infect. Dis. 146, 313-321, 1982.
3. Barker, W. H., and Mullooly, J. P. Underestimation of the role of pneumonia and influenza in causing excess mortality. Am. J. Public Health 71, 643-645, 1981.
4. Douglas, R. G., Jr. Prophylaxis and treatment of influenza. N. Engl. J. Med. 322, 443, 1990.
5. Centers for Disease Control and Prevention. Prevention and control of influenza: Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR 42, (RR-6), 1-15, 1993.
6. Fireman, P., Friday, G., and Kumate, J. Effect of measles vaccine on immunologic responsiveness. Pediatrics 43, 264-272, 1969.
7. Mangi, R. J., Niederman, J. C., Kelleher, J. E., Jr., et al. Depression of cell-mediated immunity during acute infectious mononucleosis. N. Engl. J. Med. 291, 1149, 1974.
8. Belsey, M. A. Tuberculosis and varicella infections in children. Am. J. Dis. Child. 113, 444-448, 1967.
9. Faguet, G. B. The effect of killed influenza virus vaccine on the kinetics of normal human lymphocytes. J. Infect. Dis. 43, 252-258, 1981.
10. Criswell, B. S., Couch, R. B., Greenberg, S. B., and Kimzey, S. L. The lymphocyte response to influenza in humans. Am. Rev. Respir. Dis. 120, 700-704, 1979.
11. Kauffman, C. A., Linnemann, C. C., Jr., Schiff, G. M., and Phair, J. P.: Effect of viral and bacterial pneumonias on cell-mediated immunity in humans. Infect. Immun. 13, 78-83, 1976.
12. Reed, W. P., Olds, J. W., and Kisch, A. L. Decreased skin-test reactivity associated with influenza. J. Infect. Dis. 125, 398-402, 1972.
13. Kantzier, G. B., Lauteria, S. F., Cusumano, C. L., Lee, J. D., Ganguly, R., and Waldman, R. H. Immunosuppression during influenza virus infection. Infect. Immun. 10, 996-1002, 1974.
14. Scheinberg, M. A., Blackow, N. R., Goldstein, A. L., Parrino, T. A., Rose, F. B., and Cathcart, E. S. Influenza: Responses of T-cell lymphopenia to thymosin. N. Engl. J. Med. 294, 1207-1212, 1976.
15. Dolin, R., Richman, D., Murphy, B. R., and Fauci, A. S. Cell-mediated immune responses in humans after induced infection with influenza a virus. J. Infect. Dis. 135, 714-719, 1977.
16. Allan, W., Tabi, Z., Cleary, A., and Doherty, P. C. Cellular events in the lymph node and lung of mice with influenza. J. Immunol. 144, 3980, 1990.
17. Lightman, S., Cobbold, S., Waldmann, H., and Askonas, B. A. Do L3T4 T cells act as effector cells in protection against influenza virus infection. Immunology 62, 139, 1987.
18. Jones, P. D., and Ada, G. L. Influenza virus-specific antibody secreting cells in the murine lung during primary influenza virus infection. J. Virol. 60, 614, 1986.
19. Yap, K. L., and Ada, G. L. The effect of specific antibody on the generation of cytotoxic T lymphocytes and the recovery of mice from influenza virus infection. Scand. J. Immunol. 10, 325, 1989.
20. Renegar, K. B., and Small, P. A., Jr. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65, 2146-2148, 1991.
21. Yewdell, J. W., and Hackett, C. J. Specificity and function of T lymphocytes induced by influenza A viruses. In "The Influenza Viruses" (R. M. Krug, Ed.), pp. 361-429, Plenum, New York.
22. Bender, B. S., Croghan, T., Zhang, L., and Small, P. A., Jr. Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J. Exp. Med. 175, 1143-1145, 1992.
23. Scherle, P. A., Palladino, G., and Gerhard, W. Mice can recover from pulmonary influenza virus infection in the absence of class 1-restricted cytotoxic T cells. J. Immunol. 148, 212-217, 1992.
24. Bukowski, J., Woda, B., Habu, S., Okumura, K., and Welsh, R. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131, 1531, 1983.
25. Welsh, R. Do natural killer cells play a role in virus infections. Antiviral Res. 1, 5, 1981.
26. Lotzova, E., and Herberman, R., Eds. "Immunobiology of Natural Killer Cells," Vol. I and II, CRC Press, Boca Raton, FL, 1986.
27. Allavena, P. G., Scale, G., Djeu, J. Y., Oppenheim, J. J., and Herberman, R. B. Production of multiple cytokines by clones of human large granular lymphocytes. Cancer Immunol. Immunother. 19, 121, 1985.
28. Whiteside, T. L., and Herberman, R. B. The role of natural killer cells in human disease. Clin. Immunol. Immunopathol. 53, 1-23, 1989.
29. Aoki, R., Usuda, T., Miyakoshi, H., et al. Low NK syndrome (LNKS): Clinical and immunologic features. Nat. Immun. Cell Growth Regul. 6, 116-128, 1987.
30. Biron, C., Byron, K. S., and Sullivan, J. Severe herpes virus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320, 1731-1735, 1989.
31. Doyle, W. J., Skoner, D. P., Hayden, F., Buchman, C. A., Seroky, J. T., and Fireman, P. Nasal and otologic effects of experimental influenza A virus infection. Ann. Otol. Rhinol. Laryngol. 103, 59-69, 1994.
32. Doyle, W. J., Skoner, D. P., Fireman, P., Seroky, J. T., Green, L, Ruben, F., Kardatzke, D. R., and Gwaltney, J. M. Rhinovirus 39 infection in allergic and non-allergic subjects. J. Allergy Clin. Immunol. 89, 968-978, 1992.
33. Tobita, K., Sugiura, A., Enomoto, C., and Furuyama, M. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. (Berlin) 162, 9-14, 1975.
34. Dowdle, W. R., Kendal, A. P., and Noble, G. R. Influenza viruses. In "Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections," 5th ed. (E. H. Lennette and N. J. Schmidt, Eds.), pp. 585-609, Am. Public Health Assoc. Washington, DC, 1979.
35. Heo, D. S., Whiteside, T. L., Johnson, J. T., Chen, K., Barnes, E. L., and Herberman, R. B. Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck. Cancer Res. 47, 6353-6362, 1987.
36. Whiteside, T. L., Bryant, J., Day, R., and Herberman, R. B. Natural killer cytotoxicity in the diagnosis of immune dysfunction: Criteria for a reproducible assay. J. Clin. Lab. Anal. 4, 102- 114, 1990.
37. Steel, R. G. D., and Torrie, J. H. "Principles and Procedures of Statistics," McGraw-Hill, New York, and 1980.
38. Suss, J., Schmidt, S., Kretschmar, M., and Wohanka, N. The modulation of the specific and non-specific host response in case of influenza virus infection and vaccination in man. Exp. Pathol. 41, 121-134, 1991.
39. Reichman, R. C., Pons, V. G., Murphy, B. R., Caplan, E. A., and Dolin, R. Cell-mediated cytotoxicity following influenza infection and vaccination in humans. J. Med. Virol. 4, 1-14, 1979.
40. Hennet, T., Ziltener, H. J., Frei, K., and Peterhans, E. A kinetic study of immune mediators in the lungs of mice infected with influenza a virus. J. Immunol. 149, 932-939, 1992.
41. Skoner, D. P., Whiteside, T. L., Wilson, J. W., Doyle, W. J., Herberman, R. B., and Fireman, P. Effect of rhinovirus 39 infection on cellular immune parameters in allergic and non-allergic subjects. J. Allergy Clin. Immunol. 92, 732-743, 1993.
42. Griffin, D. E., Ward, B. J., Jauregui, E., Johnson, R. T., and Vaisberg, A. Natural killer cell activity during measles. Clin. Exp. Immunol. 81, 218-224, 1990.
43. Sullivan, J. L., Mayner, R. E., Barry, D. W., and Ennis, F. A. Influenza virus infection in nude mice. J. Infect. Dis. 133, 91-94, 1976.
44. Wyde, P. R., Couch, R. B., Mackler, B. F. Cate, T. R., and Levy, B. M. Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect. Immun. 15, 221-229, 1977.
45. Cannon, M. J., Stott, E. J., Taylor, G., and Askonas, B. A. Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunology 62, 133, 1987.
46. Moskophidis, D., Cobbold, S. P., Waldmann, H., and Lehmann-Grube, F. Mechanism of recovery from acute virus infection: Treatment of lymphocytic choriomeningitis virus-infected mice with monoclonal antibodies reveals that Lyt-2+ T lymphocytes mediate clearance of virus and regulate the antiviral antibody response. J. Virol. 61, 1867-1874, 1987.
47. Kuwano, K., Scott, M., Young, J. F., and Ennis, F. A. HA2 subunit of influenza A H1 and H2 subtype viruses induces a protective cross-reactive cytotoxic T-lymphocyte response. J. Immunol. 140, 1264-1268, 1988.
48. Kurane, I., and Ennis, F. A. Cytotoxic T lymphocytes in dengue virus infection. Microbiol. Immunol. 189, 93-106, 1994.
49. Cannon, M. J., Openshaw, PJM, and Askonas, B. A. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus. J. Exp. Med. 168, 1163, 1988.
50. Alwan, W. H., Record, F. M., and Openshaw, P. J. M. Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J. Immunol. 150, 5211-5218, 1993.
51. Baumgarth, N., Brown, L., Jackson, D., and Kelso, A. Novel features of the respiratory tract T-cell response to influenza virus infection: Lung T cells increase expression of gamma Interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J. Virol. 68, 7575-7581, 1994.
52. Mock, D. J., Domurat, F., Roberts, N. J., Jr., Walsh, E. E., Licht, M. R., and Keng, P. Macrophages are required for influenza virus infection of human lymphocytes. J. Clin. Invest. 79, 620-624, 1987.
53. Fauci, A. S. The human immunodeficiency virus: Infectivity and mechanisms of pathogenesis. Science 239, 617, 1988.
54. Arango, M., Oropeza, F., Anderson, O., Contreras, C. E., Bianco, N. E., and Yarzabal, L. Circulating immune complexes and in vitro cell reactivity in paracoccidioidomycosis. Mycopathologia 79, 153-158, 1982.
55. Mehra, X., Brennan, P. J., Rada, E., Convit, J., and Bloom, B. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature 308, 194-196, 1984.
56. Ellner, J. J., and Daniel, T. M. Immunosuppression by mycobacterial arabinomannan. Clin. Exp. Immunol. 35, 250-257, 1979.
57. Rossi, G. A., Balbi, B., and Manca, F. Tuberculous pleural effusions: Evidence for selective presence of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection. Am. Rev. Respir. Dis. 136, 575-579, 1987.